efficacy of oral semaglutide and safety once-daily 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial Effectiveness of Oral versus Injectable

18 In these patients, pre-existing risk factors for biliary disease, such as insulin resistance (IR), dyslipidemia, and metabolic alterations, predispose them to abnormal bile composition and an increased risk of gallstone formation

We maintain a weight-inclusive environment where teens receive evidence-based care without judgment or shame

Exenatide is based on exendin-4, a peptide found in Gila monster saliva, whilst semaglutide is a modified version of human GLP-1

Acknowledgments Technical assistance was provided by Annette F Bjerre, Marianne B Jensen, Pia Jensen, Lenette S Jrgensen, Anette Kirstine Lauridsen, Gitte Norup, Jette E Svendsen and Lene Walander

Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study